{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T18:58:20Z","timestamp":1791140300286,"version":"4.1.0"},"reference-count":87,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006107","name":"Gil Medical Center, Gachon University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006107","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.atherosclerosis.2014.01.051","type":"journal-article","created":{"date-parts":[[2014,2,6]],"date-time":"2014-02-06T23:00:59Z","timestamp":1391727659000},"page":"721-728","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":117,"title":["Modulation of adiponectin as a potential therapeutic strategy"],"prefix":"10.1016","volume":"233","author":[{"given":"Soo","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Quon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang Kon","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.2009.976","article-title":"Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis","volume":"302","author":"Li","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib2","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1001\/jama.291.14.1730","article-title":"Plasma adiponectin levels and risk of myocardial infarction in men","volume":"291","author":"Pischon","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib3","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1001\/jama.289.14.1799","article-title":"Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial","volume":"289","author":"Esposito","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib4","doi-asserted-by":"crossref","first-page":"376","DOI":"10.2337\/diacare.25.2.376","article-title":"Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients","volume":"25","author":"Yang","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib5","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.atherosclerosis.2008.09.021","article-title":"Differential metabolic effects of pravastatin and simvastatin in hypercholesterolemic patients","volume":"204","author":"Koh","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib6","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1161\/01.CIR.0000143085.86697.13","article-title":"Additive beneficial effects of losartan combined with simvastatin in the treatment of hypercholesterolemic, hypertensive patients","volume":"110","author":"Koh","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib7","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.amjcard.2012.03.030","article-title":"One-year consumption of a grape nutraceutical containing resveratrol improves the inflammatory and fibrinolytic status of patients in primary prevention of cardiovascular disease","volume":"110","author":"Tome-Carneiro","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib8","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/cvr\/cvr009","article-title":"Effect of S-adenosylmethionine on neointimal formation after balloon injury in obese diabetic rats","volume":"90","author":"Lim","year":"2011","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib9","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2174\/1568008033340090","article-title":"Dual roles of adiponectin\/Acrp30 in\u00a0vivo as an anti-diabetic and anti-atherogenic adipokine","volume":"3","author":"Yamauchi","year":"2003","journal-title":"Curr Drug Targets Immune Endocr Metabol Disord"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib10","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.bbrc.2008.08.009","article-title":"Adiponectin prevents atherosclerosis by increasing cholesterol efflux from macrophages","volume":"375","author":"Tsubakio-Yamamoto","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib11","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s11883-005-0076-3","article-title":"Adipocytokines: emerging therapeutic targets","volume":"7","author":"Matsuzawa","year":"2005","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib12","doi-asserted-by":"crossref","first-page":"26746","DOI":"10.1074\/jbc.270.45.26746","article-title":"A\u00a0novel serum protein similar to C1q, produced exclusively in adipocytes","volume":"270","author":"Scherer","year":"1995","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib13","doi-asserted-by":"crossref","first-page":"9073","DOI":"10.1074\/jbc.M207198200","article-title":"Structure-function studies of the adipocyte-secreted hormone Acrp30\/adiponectin. Implications fpr metabolic regulation and bioactivity","volume":"278","author":"Pajvani","year":"2003","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib14","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1128\/MCB.00931-06","article-title":"Secretion of the adipocyte-specific secretory protein adiponectin critically depends on thiol-mediated protein retention","volume":"27","author":"Wang","year":"2007","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib15","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.atherosclerosis.2013.04.014","article-title":"Total and high molecular weight adiponectin levels and risk of cardiovascular disease in individuals with high blood glucose levels","volume":"229","author":"Saito","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib16","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nature01705","article-title":"Cloning of adiponectin receptors that mediate antidiabetic metabolic effects","volume":"423","author":"Yamauchi","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib17","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.bbrc.2003.11.042","article-title":"Expression of adiponectin receptors in pancreatic beta cells","volume":"312","author":"Kharroubi","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib18","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/ncb1404","article-title":"APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function","volume":"8","author":"Mao","year":"2006","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib19","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1007\/s00125-004-1359-x","article-title":"Adiponectin receptors gene expression and insulin sensitivity in non-diabetic Mexican Americans with or without a family history of Type 2 diabetes","volume":"47","author":"Civitarese","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib20","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1210\/jc.2005-2556","article-title":"Circulating adiponectin and expression of adiponectin receptors in human skeletal muscle: associations with metabolic parameters and insulin resistance and regulation by physical training","volume":"91","author":"Bluher","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib21","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1007\/s00125-011-2173-x","article-title":"Increased abundance of the adaptor protein containing pleckstrin homology domain, phosphotyrosine binding domain and leucine zipper motif (APPL1) in patients with obesity and type 2 diabetes: evidence for altered adiponectin signalling","volume":"54","author":"Holmes","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib22","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1172\/JCI29126","article-title":"Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome","volume":"116","author":"Kadowaki","year":"2006","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib23","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.2337\/diabetes.55.04.06.db05-1298","article-title":"EIF4A2 is a positional candidate gene at the 3q27 locus linked to type 2 diabetes in French families","volume":"55","author":"Cheyssac","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib24","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.bbrc.2003.12.058","article-title":"Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptors PPARalpha, PPARgamma, and LXR","volume":"314","author":"Chinetti","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib25","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1161\/01.CIR.0000127953.98131.ED","article-title":"Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages","volume":"109","author":"Kumada","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib26","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/90984","article-title":"The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity","volume":"7","author":"Yamauchi","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib27","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.bbrc.2004.01.049","article-title":"Adiponectin suppresses proliferation and superoxide generation and enhances eNOS activity in endothelial cells treated with oxidized LDL","volume":"315","author":"Motoshima","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"issue":"32","key":"10.1016\/j.atherosclerosis.2014.01.051_bib28","doi-asserted-by":"crossref","first-page":"5427","DOI":"10.2174\/092986712803833155","article-title":"Structure, signalling and physiologic role of adiponectin \u2013 dietary and exercise-related variations","volume":"19","author":"Hickman","year":"2012","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib29","doi-asserted-by":"crossref","first-page":"45021","DOI":"10.1074\/jbc.M307878200","article-title":"Adiponectin stimulates production of nitric oxide in vascular endothelial cells","volume":"278","author":"Chen","year":"2003","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib30","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1161\/01.RES.0000194328.57164.36","article-title":"Adiponectin inhibits endothelial synthesis of interleukin-8","volume":"97","author":"Kobashi","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib31","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.atherosclerosis.2010.01.001","article-title":"Impact of HDL on adipose tissue metabolism and adiponectin expression","volume":"210","author":"Van","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib32","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.2337\/diacare.28.9.2181","article-title":"Low plasma adiponectin levels are associated with increased hepatic lipase activity in\u00a0vivo","volume":"28","author":"Schneider","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib33","doi-asserted-by":"crossref","DOI":"10.1111\/obr.12064","article-title":"Adiponectin and lipoprotein metabolism","author":"Christou","year":"2013","journal-title":"Obes Rev"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib34","first-page":"826","article-title":"Combined impact of adiponectin and retinol-binding protein 4 on metabolic syndrome in elderly people: the Korean Longitudinal Study on Health and Aging","volume":"18","author":"Lim","year":"2010","journal-title":"Obes\u00a0(Silver Spring)"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib35","doi-asserted-by":"crossref","first-page":"252","DOI":"10.4093\/dmj.2013.37.4.252","article-title":"Serum adiponectin and type 2 diabetes: a 6-year follow-up cohort study","volume":"37","author":"Jee","year":"2013","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib36","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1093\/eurheartj\/ehl153","article-title":"Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain","volume":"27","author":"Cavusoglu","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib37","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1161\/CIRCULATIONAHA.112.135202","article-title":"Associations of total and high-molecular-weight adiponectin with all-cause and cardiovascular mortality in older persons: the Cardiovascular Health Study","volume":"126","author":"Kizer","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib38","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.atherosclerosis.2011.11.038","article-title":"Adiponectin is associated with increased mortality and heart failure in patients with stable ischemic heart disease: data from the Heart and Soul Study","volume":"220","author":"Beatty","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib39","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jama.2012.113905","article-title":"Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis","volume":"309","author":"Flegal","year":"2013","journal-title":"JAMA"},{"issue":"Suppl.\u00a02","key":"10.1016\/j.atherosclerosis.2014.01.051_bib40","doi-asserted-by":"crossref","first-page":"S276","DOI":"10.2337\/dcS13-2023","article-title":"Obesity paradox does exist","volume":"36","author":"Hainer","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib41","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1056\/NEJMoa021067","article-title":"Walking compared with vigorous exercise for the prevention of cardiovascular events in women","volume":"347","author":"Manson","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib42","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1210\/jc.2007-2028","article-title":"Insulin-sensitizing effects of exercise on adiponectin and retinol-binding protein-4 concentrations in young and middle-aged women","volume":"93","author":"Lim","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib43","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1210\/jc.2008-0476","article-title":"Assessment of adiponectin and leptin as biomarkers of positive metabolic outcomes after lifestyle intervention in overweight and obese children","volume":"93","author":"Cambuli","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib44","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/joim.12062","article-title":"Effects of individual and combined dietary weight loss and exercise interventions in postmenopausal women on adiponectin and leptin levels","volume":"274","author":"Abbenhardt","year":"2013","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib45","first-page":"2198","article-title":"Adiponectin changes in relation to the macronutrient composition of a weight-loss diet","volume":"19","author":"Summer","year":"2011","journal-title":"Obes\u00a0(Silver Spring)"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib46","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1007\/s11695-011-0374-5","article-title":"Weight loss and changes in salivary ghrelin and adiponectin: comparison between sleeve gastrectomy and Roux-en-Y gastric bypass and gastric banding","volume":"21","author":"Benedix","year":"2011","journal-title":"Obes Surg"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib47","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1210\/jcem.86.8.7741","article-title":"Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin","volume":"86","author":"Yang","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib48","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.cmet.2011.05.009","article-title":"Adiponectin is required for PPARgamma-mediated improvement of endothelial function in diabetic mice","volume":"14","author":"Wong","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib49","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1161\/CIRCRESAHA.109.211797","article-title":"Adiponectin: an indispensable molecule in rosiglitazone cardioprotection following myocardial infarction","volume":"106","author":"Tao","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib50","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1161\/ATVBAHA.107.156687","article-title":"Adiponectin protects against angiotensin II-induced cardiac fibrosis through activation of PPAR-alpha","volume":"28","author":"Fujita","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib51","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.2337\/diabetes.54.12.3358","article-title":"Peroxisome proliferator-activated receptor (PPAR)alpha activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: comparison of activation of PPARalpha, PPARgamma, and their combination","volume":"54","author":"Tsuchida","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib52","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.jacc.2005.02.052","article-title":"Additive beneficial effects of fenofibrate combined with atorvastatin in the treatment of combined hyperlipidemia","volume":"45","author":"Koh","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib53","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.2337\/dc07-0015","article-title":"Fenofibrate therapy ameliorates fasting and postprandial lipoproteinemia, oxidative stress, and the inflammatory response in subjects with hypertriglyceridemia and the metabolic syndrome","volume":"30","author":"Rosenson","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib54","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.amjhyper.2004.08.033","article-title":"Insulin sensitivity and endothelial function in hypertension: a comparison of temocapril and candesartan","volume":"18","author":"Tomiyama","year":"2005","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib55","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijcard.2008.11.017","article-title":"Distinct vascular and metabolic effects of different classes of anti-hypertensive drugs","volume":"140","author":"Koh","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib56","doi-asserted-by":"crossref","first-page":"273","DOI":"10.7326\/0003-4819-118-4-199302150-00005","article-title":"Antihypertensive drug therapy and the initiation of treatment for diabetes mellitus","volume":"118","author":"Gurwitz","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib57","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1161\/CIRCULATIONAHA.105.548461","article-title":"Long-term effects of ramipril on cardiovascular events and on diabetes: results of the HOPE study extension","volume":"112","author":"Bosch","year":"2005","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2014.01.051_bib58","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1089\/ars.2013.5531","article-title":"Differential metabolic actions of specific statins: clinical and therapeutic considerations","volume":"20","author":"Lim","year":"2014","journal-title":"Antioxid Redox Signal"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2014.01.051_bib59","doi-asserted-by":"crossref","first-page":"592","DOI":"10.4070\/kcj.2012.42.9.592","article-title":"Anti-inflammatory effects of statins beyond cholesterol lowering","volume":"42","author":"Joo","year":"2012","journal-title":"Korean Circ J"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib60","doi-asserted-by":"crossref","first-page":"274","DOI":"10.2133\/dmpk.25.274","article-title":"The HMG-CoA reductase inhibitor pravastatin stimulates insulin secretion through organic anion transporter polypeptides","volume":"25","author":"Abe","year":"2010","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib61","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0014-5793(01)03007-1","article-title":"Inhibition of isoprenoid biosynthesis causes insulin resistance in 3T3-L1 adipocytes","volume":"507","author":"Chamberlain","year":"2001","journal-title":"FEBS Lett"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib62","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jacc.2009.10.053","article-title":"Atorvastatin causes insulin resistance and increases ambient glycemia in hypercholesterolemic patients","volume":"55","author":"Koh","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib63","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1001\/jama.2011.860","article-title":"Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis","volume":"305","author":"Preiss","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib64","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","article-title":"Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials","volume":"375","author":"Sattar","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib65","first-page":"87","article-title":"Comparison of pitavastatin with atorvastatin in increasing HDL-cholesterol and adiponectin in patients with dyslipidemia and coronary artery disease: the COMPACT-CAD study","volume":"62","author":"Kurogi","year":"2013","journal-title":"J\u00a0Cardiol"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib66","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1056\/NEJM199011083231901","article-title":"Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B","volume":"323","author":"Brown","year":"1990","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib67","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.metabol.2006.07.002","article-title":"Adipokines and treatment with niacin","volume":"55","author":"Westphal","year":"2006","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib68","doi-asserted-by":"crossref","first-page":"E549","DOI":"10.1152\/ajpendo.91004.2008","article-title":"Niacin stimulates adiponectin secretion through the GPR109A receptor","volume":"296","author":"Plaisance","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib69","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1107579","article-title":"Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy","volume":"365","author":"Boden","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib70","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.amjhyper.2003.09.007","article-title":"Inhibition of oxidative stress and improvement of endothelial function by amlodipine in angiotensin II-infused rats","volume":"17","author":"Zhou","year":"2004","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib71","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.2337\/dc06-2267","article-title":"Efonidipine simultaneously improves blood pressure, endothelial function, and metabolic parameters in nondiabetic patients with hypertension","volume":"30","author":"Koh","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib72","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10741-005-2344-2","article-title":"Mineralocorticoid receptors: distribution and activation","volume":"10","author":"Funder","year":"2005","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib73","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/cvr\/cvp191","article-title":"Blockade of mineralocorticoid receptor reverses adipocyte dysfunction and insulin resistance in obese mice","volume":"84","author":"Hirata","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib74","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1161\/CIRCULATIONAHA.107.748640","article-title":"Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines","volume":"117","author":"Guo","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib75","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/01.hjh.0000209993.26057.de","article-title":"Comparative effects of nebivolol and metoprolol on oxidative stress, insulin resistance, plasma adiponectin and soluble P-selectin levels in hypertensive patients","volume":"24","author":"Celik","year":"2006","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib76","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0162-0134(00)00226-9","article-title":"Effect of vanadium(IV) compounds in the treatment of diabetes: in\u00a0vivo and in\u00a0vitro studies with vanadyl sulfate and bis(maltolato)oxovandium(IV)","volume":"85","author":"Willsky","year":"2001","journal-title":"J\u00a0Inorg Biochem"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib77","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00775-013-1007-3","article-title":"Vanadyl acetylacetonate upregulates PPARgamma and adiponectin expression in differentiated rat adipocytes","volume":"18","author":"Wu","year":"2013","journal-title":"J\u00a0Biol Inorg Chem"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib78","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.biochi.2010.02.024","article-title":"Resveratrol modulates adipokine expression and improves insulin sensitivity in adipocytes: relative to inhibition of inflammatory responses","volume":"92","author":"Kang","year":"2010","journal-title":"Biochimie"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib79","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/j.1530-0277.2007.00407.x","article-title":"S-adenosylmethionine attenuates hepatic lipid synthesis in micropigs fed ethanol with a folate-deficient diet","volume":"31","author":"Esfandiari","year":"2007","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib80","doi-asserted-by":"crossref","first-page":"E298","DOI":"10.1152\/ajpendo.00319.2005","article-title":"MKR mice are resistant to the metabolic actions of both insulin and adiponectin: discordance between insulin resistance and adiponectin responsiveness","volume":"291","author":"Kim","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib81","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1172\/JCI45942","article-title":"Adiponectin suppresses gluconeogenic gene expression in mouse hepatocytes independent of LKB1-AMPK signaling","volume":"121","author":"Miller","year":"2011","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib82","doi-asserted-by":"crossref","first-page":"e44270","DOI":"10.1371\/journal.pone.0044270","article-title":"Recombinant adiponectin does not lower plasma glucose in animal models of type 2 diabetes","volume":"7","author":"Tullin","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib83","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1177\/1087057111403474","article-title":"High-throughput screening for small-molecule adiponectin secretion modulators","volume":"16","author":"Hino","year":"2011","journal-title":"J\u00a0Biomol Screen"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib84","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.1210\/jc.2007-0890","article-title":"Total and high molecular weight but not trimeric or hexameric forms of adiponectin correlate with markers of the metabolic syndrome and liver injury in Thai subjects","volume":"92","author":"Liu","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib85","doi-asserted-by":"crossref","first-page":"e63354","DOI":"10.1371\/journal.pone.0063354","article-title":"Identification of adiponectin receptor agonist utilizing a fluorescence polarization based high throughput assay","volume":"8","author":"Sun","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib86","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nature12656","article-title":"A\u00a0small-molecule AdipoR agonist for type 2 diabetes and short life in obesity","volume":"503","author":"Okada-Iwabu","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2014.01.051_bib87","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/01.HYP.0000078490.59735.6E","article-title":"Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension","volume":"42","author":"Furuhashi","year":"2003","journal-title":"Hypertension"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915014000781?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915014000781?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T16:24:06Z","timestamp":1762187046000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915014000781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":87,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0021915014000781"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.01.051","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulation of adiponectin as a potential therapeutic strategy","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.01.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}